You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MRNA Exercise Disclosure
Mock James M · SEC Form 4 · Filed Sep 8, 2026
Exercise
Reported value range
Not reported
Mock James M Chief Financial Officer
MRNA
Moderna
MRNA
Transaction date
Sep 4, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 4 days later
MRNA daily price context
Close on/before transaction
$145.55
Sep 4, 2026
First close after public filing
$135.61
Sep 9, 2026
30-day return after filing
+45.27%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,797 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001682852-26-000172
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$849.15K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA Current | Exercise | Sep 4, 2026 | Not reported |
| Moderna, Inc. MRNA | Disposition | Sep 4, 2026 | $849.15K |
| Moderna, Inc. MRNA | Exercise | Sep 4, 2026 | $0 |